Back to resultsImproving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
Primary Purpose
Non-Small Cell Lung Carcinoma (NSCLC)
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Survey
Sponsored by
About this trial
This is an interventional supportive care trial for Non-Small Cell Lung Carcinoma (NSCLC)
Eligibility Criteria
Inclusion Criteria:
- All participants must be 18 years of age or older.
- Patient participants must have Stage III, IV and/or recurrent NSCLC.
- Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change
- Patients must have working email address and internet access
Exclusion Criteria:
- Any participant who cannot understand written or spoken English.
- Any participant who is not competent to provide informed consent for study participation per the investigator.
- Any participant who cannot be present for the related study visits and/or complete the post-test assessment
Sites / Locations
- Abramson Cancer Center of the University of Pennsylvania
Outcomes
Primary Outcome Measures
Number of patient who completed surveys
Secondary Outcome Measures
Full Information
NCT ID
NCT02558998
First Posted
June 19, 2015
Last Updated
February 4, 2020
Sponsor
Abramson Cancer Center at Penn Medicine
1. Study Identification
Unique Protocol Identification Number
NCT02558998
Brief Title
Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
Official Title
Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
Study Type
Interventional
2. Study Status
Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
March 2015 (undefined)
Primary Completion Date
March 2019 (Actual)
Study Completion Date
March 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Abramson Cancer Center at Penn Medicine
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Non-Small Cell Lung Carcinoma (NSCLC)
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Other
Intervention Name(s)
Survey
Primary Outcome Measure Information:
Title
Number of patient who completed surveys
Time Frame
8 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All participants must be 18 years of age or older.
Patient participants must have Stage III, IV and/or recurrent NSCLC.
Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change
Patients must have working email address and internet access
Exclusion Criteria:
Any participant who cannot understand written or spoken English.
Any participant who is not competent to provide informed consent for study participation per the investigator.
Any participant who cannot be present for the related study visits and/or complete the post-test assessment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joshua Bauml, MD
Organizational Affiliation
Abramson Cancer Center at Penn Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Abramson Cancer Center of the University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
We'll reach out to this number within 24 hrs